You are here » Home » Companies » Company Overview » Welcure Drugs & Pharmaceuticals Ltd

Welcure Drugs & Pharmaceuticals Ltd.

BSE: 524661 Sector: Health care
NSE: N.A. ISIN Code: INE331C01017
BSE 00:00 | 12 Dec 0.56 0
(0.00%)
OPEN

0.56

HIGH

0.56

LOW

0.56

NSE 05:30 | 01 Jan Welcure Drugs & Pharmaceuticals Ltd
OPEN 0.56
PREVIOUS CLOSE 0.56
VOLUME 1000
52-Week high 1.41
52-Week low 0.50
P/E
Mkt Cap.(Rs cr) 1
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 0.56
CLOSE 0.56
VOLUME 1000
52-Week high 1.41
52-Week low 0.50
P/E
Mkt Cap.(Rs cr) 1
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Welcure Drugs & Pharmaceuticals Ltd. (WELCUREDRUGS) - Corporate Action

Search Purpose:
From: To:
ANNOUNCEMENT DATE PURPOSE REMARKS
08-10-2018 Board Meeting WELCURE DRUGS has informed BSE that the meeting of the Board of Director...
30-07-2018 Board Meeting The Company has scheduled to hold its Board Meeting and Audit Committee ...
21-04-2018 Board Meeting Audited ResultsPursuant to Regulation 29 of the SEBI ( Listing Obligatio...
15-01-2018 Board Meeting In compliance with Regulation 29 of Securities and Exchange Board of Ind...
09-10-2017 Board Meeting Quarterly Results
24-07-2017 Board Meeting Welcure Drugs has informed BSE that a meeting of the Audit Committee and...
01-05-2017 Board Meeting As required under Regulation 29 of SEBI (Listing Obligations and Disclos...
07-01-2017 Board Meeting Quarterly Results
17-10-2016 Board Meeting Welcure Drugs & Pharmaceuticals Ltd has informed BSE that the next meeti...
25-07-2016 Board Meeting Welcure Drugs & Pharmaceuticals Ltd has informed BSE that the next meeti...
25-04-2016 Board Meeting Audited Results
11-01-2016 Board Meeting Quarterly Results
12-10-2015 Board Meeting Quarterly Results
27-07-2015 Board Meeting Quarterly Results
17-01-2015 Board Meeting Quarterly Results
28-07-2014 Board Meeting Quarterly Results
21-04-2014 Board Meeting Audited Results
20-01-2014 Board Meeting Quarterly Results
28-10-2013 Board Meeting Quarterly Results
29-07-2013 Board Meeting Quarterly Results